scispace - formally typeset
J

Josep M. Antó

Researcher at Pompeu Fabra University

Publications -  523
Citations -  45951

Josep M. Antó is an academic researcher from Pompeu Fabra University. The author has contributed to research in topics: Asthma & Population. The author has an hindex of 100, co-authored 493 publications receiving 38663 citations. Previous affiliations of Josep M. Antó include University of Rochester & Centra.

Papers
More filters
Journal ArticleDOI

Methadone treatment in Spain, 1994.

TL;DR: The objective of this study was to describe the methadone treatment (MT) network in Spain, and to evaluate compliance with criteria known to influence the spread of human immunodeficiency virus (HIV).
Journal ArticleDOI

Long‐term reliability in reporting of childhood pets by adults interviewed twice, 9 years apart. Results from the European Community Respiratory Health Survey I and II

TL;DR: Long-term reliability in adult reporting of childhood pets was substantial, and not influenced by disease status, and collection of information about childhood pets from adults appears to be reliable for the purpose of studying adult allergic disease.
Journal ArticleDOI

Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease

TL;DR: Network meta-analysis adapted to multiple score comparison can be applied to prognostic scores in any medical field to identify the best scores, possibly paving the way for stratified medicine, public health, and research.
Journal ArticleDOI

Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®.

Bernardo Sousa-Pinto, +58 more
TL;DR: In this paper, the authors assessed the concurrent validity, reliability, and responsiveness of visual analog scales (VASs) used by MASK-air® users with allergic rhinitis.
Journal ArticleDOI

Functional capacity and five-year mortality in a sample of urban community elderly

TL;DR: Significantly lower survival rates were found for males, older age groups, functionally dependent subjects and for those reporting poor health, while cross-cultural validity of functional capacity based on IADL measures deserves further research.